Effect of highly active antiretroviral therapy (HAART) on HIV-1 tat protein-induced neurotoxicity.
Date
2014
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Background: HIV-1-trans-activating (Tat) protein has been associated with development of HIV associated
neurocognitive disorder (HAND). Previous studies have demonstrated that Tat protein causes
neurotoxicity through an increase in reactive oxygen species (ROS) leading to damage of proteins and
other cellular components. Tat has also been shown to cause excessive production of pro-inflammatory
cytokines. However the role of antiretroviral agents in the neuropathology of HIV is not known. The
objective of this study was to investigate whether a combination of antiretroviral drugs (Zidovudine,
Lamivudine and Efavirenz, a highly active antiretroviral therapy, HAART) is effective in reducing the
toxic effects of Tat protein in the rat hippocampus.
Materials and methods: Male Sprague-Dawley rats were divided into four groups (n=10 per group). Each
rat received bilateral intrahippocampal injection of either Tat protein (5μg/10μL) or vehicle, followed 7
days later by a combination of antiretroviral drugs (Zidovudine 12mg/kg, Lamivudine 6mg/kg and
Efavirenz 24mg/kg) or saline injected intraperitoneally, twice a day, for 7 days. After treatment, animals
were sacrificed and hippocampal tissue was collected for analysis of cleaved caspase-3, 4-
hydroxynonenal (NHE), tumor necrosis factor alpha (TNF-α), phosphorylated extracellular signal regulated
kinase (pERK) and Synaptophysin.
Results: Tat increased cleaved caspase-3 levels in the hippocampus. Antiretroviral treatment decreased
the Tat-induced increase in cleaved caspase-3. Tat increased HNE, a marker of lipid peroxidation and
reduced hippocampal synaptophysin. The latter Tat-induced effects were not reversed by antiretroviral
treatment. The antiretroviral drug combination activated the pERK pathway and increased TNF-α levels
in hippocampal tissue, independent of Tat infusion.
Discussion: Our findings showed that antiretroviral drugs reversed Tat-induced cleaved caspase-3,
reducing apoptosis but did not reverse Tat-induced increase in lipid peroxidation and the synaptic marker,
synaptophysin. The evidence suggests that the combination of antiretroviral drugs may be toxic, elevating
hippocampal pERK and TNF-α levels. However, these effects could also be beneficial to the individual,
since TNF-α has been shown to inhibit viral replication. The present results provide novel insight into the
mechanism of antiretroviral action.
Description
M. Med. Sc. University of KwaZulu-Natal, Durban 2014.
Keywords
Highly active antiretroviral therapy., HIV infections., Neurotoxicology., AIDS (Disease)--Treatment., Antiretroviral agents., Neuropharmacology., Theses--Physiology., HIV-1 tat protein., HAART.